Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000163

Chairperson & CEO sold 9,500 shares at an average $545.52 ($5,182,414)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

11 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-13 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-10-13 Sale : show line 2 in the form 10b5-1 −639 $542.76 $346,822 333,304 I
2026-10-13 Sale : show line 3 in the form 10b5-1 −2,340 $543.48 $1,271,750 330,964 I
2026-10-13 Sale : show line 4 in the form 10b5-1 −1,492 $544.56 $812,483 329,472 I
2026-10-13 Sale : show line 5 in the form 10b5-1 −1,507 $545.52 $822,102 327,965 I
2026-10-13 Sale : show line 6 in the form 10b5-1 −1,452 $546.46 $793,459 326,513 I
2026-10-13 Sale : show line 7 in the form 10b5-1 −630 $547.47 $344,908 325,883 I
2026-10-13 Sale : show line 8 in the form 10b5-1 −698 $548.49 $382,844 325,185 I
Open-market sales · 9,500 sh · avg $545.52 · $5,182,414

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-13 Exercise or conversion : show line 12 in the form 10b5-1 Stock Option −9,500 242,910 I
Loading xslF345X06/primarydocument.xml…